Overview
Smart money at a glance
Filings to Oct 2, 2026Net selling: insiders sold $919K and bought $250K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$670K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 2- Open
- $21.26
- 52-wk high
- $73.68
- High
- $21.34
- 52-wk low
- $11.50
- Low
- $20.24
- Prev close
- $21.17
- Mkt cap
- $358.8M
- Volume
- 188.8K
- Fwd P/E
- 3.4x
- Beta
- 0.89
- P/S
- 0.4x
- P/B
- 43.9x
- Profit margin
- -28.5%
- Op margin
- +12.8%
- ROE
- -646.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CTEV filings
Are insiders buying or selling Claritev Corporation (CTEV) stock?
Net selling: insiders sold $919K and bought $250K of CTEV stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. $276K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Misencik, Tiffani (SVP, Chief Growth Officer), who sold $355K. The latest filing was on Sep 22, 2026.
Which members of Congress have traded CTEV recently?
None. No member of Congress disclosed a CTEV trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CTEV smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in CTEV right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 14.9% above what analysts expected.
Earnings per share
-$4.10 expected
Reports Nov 6, 2026, in 35 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $246.0M | $246.6M | $244.7M | $257.5M |
| Cost of what it sold | $62.1M | $78.0M | $180.2M | $234.1M |
| Gross profit | $183.9M | $168.5M | $64.5M | $23.4M |
| What it spent | ||||
| Sales and admin | $48.0M | $48.1M | $57.8M | $55.4M |
| Other operating costs | $125.8M | $111.7M | — | — |
| Total operating expenses | $173.8M | $159.8M | $57.8M | $55.4M |
| What was left | ||||
| Operating profit | $10.1M | $8.7M | $6.7M | $23.4M |
| Interest on debt | $101.2M | $99.4M | $97.9M | $100.3M |
| Profit before tax | -$46.1M | -$106.9M | -$92.7M | -$76.6M |
| Tax | $23.6M | -$26.3M | -$19.2M | -$17.4M |
| Net profit | -$69.8M | -$80.6M | -$73.6M | -$59.2M |
| EBITDA | $167.0M | $104.8M | $116.8M | $202.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace